Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31665578

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Oct 31
First author
Perl AE

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Feb;17(2):69. doi: 10.1038/s41571-019-0305-2.
    note
    Source null
    related pmid
    31745291
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 May 12;386(19):1868. doi: 10.1056/NEJMx220003.
    note
    Source null
    related pmid
    35544407
    relationship
    Erratum in

Authors and identifiers

  1. name
    Perl AE
    type
    Author
  2. name
    Martinelli G
    type
    Author
  3. name
    Cortes JE
    type
    Author
  4. name
    Neubauer A
    type
    Author
  5. name
    Berman E
    type
    Author
  6. name
    Paolini S
    type
    Author
  7. name
    Montesinos P
    type
    Author
  8. name
    Baer MR
    type
    Author
  9. name
    Larson RA
    type
    Author
  10. name
    Ustun C
    type
    Author
  11. name
    Fabbiano F
    type
    Author
  12. name
    Erba HP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Perl AE
    type
    Author
  2. name
    Martinelli G
    type
    Author
  3. name
    Cortes JE
    type
    Author
  4. name
    Neubauer A
    type
    Author
  5. name
    Berman E
    type
    Author
  6. name
    Paolini S
    type
    Author
  7. name
    Montesinos P
    type
    Author
  8. name
    Baer MR
    type
    Author
  9. name
    Larson RA
    type
    Author
  10. name
    Ustun C
    type
    Author
  11. name
    Fabbiano F
    type
    Author
  12. name
    Erba HP
    type
    Author
bibliography ids
  1. nci-bib-2a11a30ede18a23d74c6f051
book metadata
content sha256
7092fb22126a791034cabbcd01f5dbc50236a0a290541725429d18016c2be982
document type
citation
dois
  1. 10.1056/NEJMoa1902688
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31665578
immutable id
pubmed:31665578@7092fb22126a791034cabbcd01f5dbc50236a0a290541725429d18016c2be982
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
18
name
The New England journal of medicine
nlm unique id
0255562
pages
1728-1740
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Feb;17(2):69. doi: 10.1038/s41571-019-0305-2.
    note
    Source null
    related pmid
    31745291
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 May 12;386(19):1868. doi: 10.1056/NEJMx220003.
    note
    Source null
    related pmid
    35544407
    relationship
    Erratum in
outcomes validated
false
pmid
31665578
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
baa4534f47f5499f1ae9ebcb5da606536bbd173c1e87815481e450aa8962cdbe
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2019 Oct 31
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31665578/
title
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.

Preserved source evidence · Not medical advice